CD326 (EpCAM), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD326 (EpCAM), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD326 (EpCAM), Human |
| Clone | HEA-125 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1κ |
| Format | Vio Bright B515 conjugate |
| Size | 30 tests in 60 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD326 (EpCAM) Antibody, anti-human, Vio® Bright B515. Clone HEA-125 recognizes the CD326 antigen, also known as human epithelial antigen (HEA), epithelial cell adhesion molecule (EpCAM), or epithelial-specific antigen (ESA), and is involved in cell adhesion. The CD326 antigen is broadly expressed on the basolateral surface of carcinoma and epithelial cells in tissues or on circulating tumor cells and cancer stem cells, but is not found on melanoma, neuroblastoma, sarcoma, lymphoma, leukemia cells, or normal fibroblasts. |
| Immunogen | n/a |
| Other Names | EGP40, Ep-CAM, KSA, MK-1, TROP1 |
| Gene, Accession # | Gene ID: 4072 |
| Catalog # | 130-113-829 |
| Price | $189 |
| Order / More Info | CD326 (EpCAM), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Moldenhauer, G. et al. (1987) Epithelium specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br. J. Cancer 56: 714-721. | Metsuyanim, S. et al. (2009) Expression of stem cell markers in the human fetal kidney. PLoS One 4 (68): e6709. | Sheridan, C. et al. (2006) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8 (5): R59. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies